CHE
Chemed
CHE • NYSE
Chemed is a medical - care facilities company in the healthcare sector trading on NYSE, led by CEO Kevin J. McNamara, with a market cap of $5.1B.
CEOKevin J. McNamara
Next Earnings
Upcoming earnings announcement for Chemed
Date
Wednesday, April 22, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$5.20
Revenue Estimate
$648.9M
Earnings History
Past 12 earnings reports for Chemed
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | $6.42Est: $6.85 | -6.3% | $639.3MEst: $657.9M | -2.8% |  10-K |
| Oct 28, 2025 | Q3 2025 | $5.27Est: $5.19 | +1.5% | $624.9MEst: $626.8M | -0.3% | — |
| Jul 29, 2025 | Q2 2025 | $4.27Est: $4.72 | -9.5% | $618.8MEst: $622.3M | -0.6% | 10-Q |
| Apr 23, 2025 | Q1 2025 | $5.63Est: $5.55 | +1.4% | $646.9MEst: $641.8M | +0.8% | 10-Q |
| Feb 26, 2025 | Q4 2024 | $6.83Est: $6.78 | +0.7% | $640.0MEst: $636.1M | +0.6% | 10-K |
| Oct 29, 2024 | Q3 2024 | $5.64Est: $5.76 | -2.1% | $606.2MEst: $612.2M | -1.0% | 10-Q |
| Jul 24, 2024 | Q2 2024 | $5.47Est: $5.59 | -2.1% | $595.9MEst: $599.2M | -0.6% | 10-Q |
| Apr 24, 2024 | Q1 2024 | $5.20Est: $5.48 | -5.1% | $589.2MEst: $591.5M | -0.4% | 10-Q |
| Feb 27, 2024 | Q4 2023 | $6.60Est: $6.25 | +5.6% | $585.9MEst: $586.6M | -0.1% | 10-K |
| Oct 25, 2023 | Q3 2023 | $5.32Est: $4.90 | +8.6% | $564.5MEst: $558.4M | +1.1% | 10-Q |
| Jul 26, 2023 | Q2 2023 | $4.71Est: $5.09 | -7.5% | $553.8MEst: $562.5M | -1.6% | 10-Q |
| Apr 26, 2023 | Q1 2023 | $4.82Est: $4.81 | +0.2% | $560.2MEst: $548.8M | +2.1% | — |